Dystroglycan in development and disease

Current Opinion in Cell Biology

Volumn 10, Issue 5, 1998, Pages 594-601

  Durbeej, Madeleine ^a   Henry, Michael D ^a   Campbell, Kevin P ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGRIN; CELL SURFACE RECEPTOR; DYSTROGLYCAN; LAMININ;

CELL SURFACE; GENE DISRUPTION; MORPHOGENESIS; MUSCULAR DYSTROPHY; ORGANOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYNAPTOGENESIS;

EID: 0031669335     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(98)80034-3     Document Type: Article

References (71)

1. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature. 345:1990;315-319.
2. Ohlendieck K, Campbell KP. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol. 115:1991;1685-1694.
3. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature. 355:1992;696-702.
4. Sunada Y, Bernier SM, Kozak CA, Yamada Y, Campbell KP. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain to dy locus. J Biol Chem. 269:1994;13729-13732.
5. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP. Identification and characterization of the dystrophin anchoring site on β-dystroglycan. J Biol Chem. 270:1995;27305-27310.
6. Ervasti JM, Campbell KP. A role for dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol. 122:1993;809-823.
7. Henry MD, Campbell KP. Dystroglycan: an extracellular matrix receptor linked to the cytoskeleton. Curr Opin Cell Biol. 8:1996;625-631.
8. Straub V, Campbell KP. Muscular dystrophies and the dystrophinglycoprotein complex. of special interest Curr Opin Neurol. 10:1997;168-175 A comprehensive review about the progress and current status of muscular dystrophies associated with the dystrophin-glycoprotein complex.
9. Gorecki DC, Derry JMJ, Barnard EA. Dystroglycan: brain localization and chromosome mapping in the mouse. Hum Mol Gen. 3:1994;1589-1597.
10. Durbeej M, Larsson E, Ibraghimov-Beskrovnaya O, Roberds SL, Campbell KP, Ekblom P. Non-muscle α-dystroglycan is involved in epithelial development. J Cell Biol. 130:1995;79-91.
11. Schofield JN, Gorecki DC, Blake DJ, Davies K, Edwards YH. Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: a comparison with utrophin and the apodystrophins. Dev Dyn. 204:1995;178-185.
12. Yotsomoto S, Fujiwara H, Horton JH, Mosby TA, Wang X, Cui Y, Ko MSH. Cloning and expression analyses of mouse dystroglycan gene: specific expression in maternal decidua at the peri-implantation stage. Hum Mol Gen. 5:1996;1259-1267.
13. Matsumura K, Yamada H, Fujita S, Fukuta-Ohi H, Tanaka T, Campbell KP, Shimizu T. Peripheral nerve dystroglycan: its function and potential role in the molecular pathogenesis of neuromuscular diseases. Fukuyama Y, Osawa M, Saito K. Congenital Muscular Dystrophies. 1997;267-273 Elsevier Science BV, Amsterdam.
14. Schmitz F, Drenckhahn D. Dystrophin in the retina. Prog Neurobiol. 53:1997;547-560.
15. Williamson RA, Henry MD, Daniels KJ, Hrstka RF, Lee JC, Sunada Y, Ibraghimov-Beskrovnaya O, Campbell KP. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. of outstanding interest Hum Mol Gen. 6:1997;831-841 This paper provides genetic evidence that dystroglycan is required for early embryonic development. Reichert's membrane is disrupted in mutant mice, suggesting a role for dystroglycan in basement membrane formation.
16. Durbeej M, Henry MD, Ferletta M, Campbell KP, Ekblom P. Distribution of dystroglycan in normal adult mouse tissues. of special interest J Histochem Cytochem. 46:1998;449-457 This paper provides a comprehensive description of the expression pattern of dystroglycan in adult mouse tissues.
17. Gee SH, Blacher RW, Douville PJ, Provost PR, Yurchenco PD, Carbonetto S. Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J Biol Chem. 268:1993;14972-14980.
18. Ruegg MA, Bixby JL. Agrin orchestrates synaptic differentiation at the vertebrate neuromuscular junction. of special interest Trends Neurosci. 21:1997;22-27 This paper summarizes recent advances in understanding the role of agrin in controlling synaptic differentiation at the neuromuscular junction.
19. James M, Man NT, Wise CJ, Jones GE, Morris GE. Utrophin-dystroglycan complex in membranes of adherent cultures cells. Cell Motil Cytoskeleton. 23:1996;163-174.
20. Lim LE, Campbell KP. The sarcoglycan complex in limb-girdle-muscular dystrophy. Curr Opin Neurol. 1998;. in press.
21. Matsumura K, Chiba A, Yamada H, Fukuta-Ohi H, Fulita S, Enso T, Kobata A, Anderson LVB, Kanazawa I, Campbell KP, Shimizu T. A role of dystroglycan in Schwannoma cell adhesion to laminin. of special interest J Biol Chem. 272:1997;13904-13910 The monoclonal antibody IIH6, known to perturb the interaction of α-dystroglycan with laminin 1, drastically reduced the adhesion of RT4 cells to laminin 1 but not to fibronectin.
22. Montanaro F, Gee SH, Jacobson C, Lindenbaum MH, Froehner SC, Carbonetto S. Laminin and α-dystroglycan mediate acetylcholine receptor aggregation via a MuSK-independent pathway. of special interest J Neurosci. 18:1998;1250-1260 See annotation to [54]. In addition, α-dystroglycan is implicated as the receptor that mediates the muscle specific receptor tyrosine kinase (MuSK) independent acetylcholine receptor (AChR) aggregation.
23. Jacobson C, Montanaro F, Lindenbaum M, Carbonetto S, Ferns M. Alpha-dystroglycan functions in acetylcholine receptor aggregation but is not a coreceptor for agrin-MuSK signaling. J Neurosci. 18:1998;6340-6348.
24. Rambukkana A, Yamada H, Zanazzi G, Mathus T, Salzer JL, Yurchenco P, Campbell KP, Fischetti VA. α-dystroglycan is a Schwann cell receptor for Mycobacterium leprae. Science. 1998;. submitted.
25. Ibraghimov-Beskrovnaya O, Milatovich A, Ozelic T, Yan B, Koepnick K, Francke U, Campbell KP. Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol Gen. 2:1993;1651-1657.
26. Brancaccio A, Ruegg MA, Engel J. Cloning and sequencing of mouse skeletal muscle alpha-dystroglycan. Matrix Biol. 14:1994;681-685.
27. Deyst KA, Bowe MA, Leszyk JD, Fallon JR. The α-dystroglycan β-dystroglycan complex membrane organization and relationship to and agrin receptor. J Biol Chem. 270:1995;25956-25959.
28. Ervasti JM, Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell. 66:1991;1121-1131.
29. Ervasti JM, Burwell AL, Geissler AL. Tissue-specific heterogeneity in α-dystroglycan sialoglycosylation. of special interest J Biol Chem. 272:1997;22315-22321 Data presented here suggest that the sialic acid moieties of α-dystroglycan do not appear to be necessary for α-dystroglycan binding to laminin-1 or merosin.
30. Yamada H, Shimizu T, Tanaka T, Campbell KP, Matsumura K. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett. 352:1994;49-53.
31. Brancaccio A, Schultess T, Gesemann M, Engel J. Electron microscopic evidence for a mucin-like region in chick muscle α-dystroglycan. FEBS Lett. 368:1995;139-142.
32. Smalheiser NR, Kim E. Purification of cranin, a laminin binding membrane protein. J Biol Chem. 270:1995;15425-15433.
33. Yamada H, Chiba A, Endo T, Kobata A, Anderson LVB, Hori H, Fukuta-Ohi H, Kanazawa I, Campbell KP, Shimizu T, Matsumura K. Characterization of dystroglycan-laminin interaction in peripheral nerve. J Neurochem. 66:1996;1518-1524.
34. Chiba A, Matsumura K, Yamada H, Inazu T, Shimizy T, Kusunoki S, Kanazawa I, Kobata A, Endo T. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. of special interest J Biol Chem. 272:1997;2156-2162 This paper identifies the structure of the major component of the sialylated O-linked oligosaccharides of peripheral nerve α-dystroglycan. Furthermore, it is suggested that the unique oligosaccharide contributes to the laminin-binding activity of α-dystroglycan.
35. Brancaccio A, Schultess T, Gesemann M, Engel J. The N-terminal region of α-dystroglycan is an autonomous globular domain. of special interest Eur J Biochem. 246:1997;166-172 By expressing amino-terminal fragments of α-dystroglycan in Escherichia coli it is demonstrated that the amino-terminal part of α-dystroglycan has a globular shape and does not bind laminin or agrin.
36. Crosbie RH, Heighway J, Venzke DP, Lee JC, Campbell KP. Sarcospan, the 25 kDa transmembrane component of the dystrophin-glycoprotein complex. J Biol Chem. 272:1997;31221-31224.
37. Maecker HT, Todd SC, Levy S. The tetraspanin superfamily: molecular facilitators. FASEB J. 11:1997;428-442.
38. Pall EA, Bolton KM, Ervasti JM: Differential heparin binding of skeletal muscle α-dystroglycan binding to laminins. J Biol Chem 271:3817-3821.
39. McDearmon EL, Burwell AL, Combs AC, Renley BA, Sdano MT, Ervasti JM. Differential heparin sensitivity of α-dystroglycan binding to laminins expressed in normal and dy/dy mouse skeletal muscle. J Biol Chem. 273:1998;24139-24144.
40. Denzer AJ, Brandenberger R, Gesemann M, Chiquet M, Ruegg MA. Agrin binds to the nerve-muscle basal lamina via laminin. J Cell Biol. 137:1997;671-683.
41. Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP. Association of dystrophin-related protein with dystrophin-associated proteins in mdx muscle. Nature. 360:1992;588-591.
42. Yamada H, Denzer AJ, Hori H, Tanaka T, Anderson LVB, Fujita S, Fukuta-Ohi H, Shimizy T, Ruegg MA, Matsumura K. Dystroglycan is a dual receptor for agrin and laminin-2 in Schwann cell membrane. J Biol Chem. 271:1996;23418-23423.
43. Tian M, Jacobsen C, Gee SH, Campbell KP, Carbonetto S, Jucker M. Dystroglycan in the cerebellum is a laminin α2 chain binding protein at the glial-vascular interface and is expressed in Purkinje cells. Eur J Neurosci. 8:1996;2739-2747.
44. Gorecki DC, Barnard EA. Specific expression of G-dystrophin (Dp71) in the brain. Neuroreport. 6:1995;893-986.
45. Greenberg DS, Schatz Y, Levy Z, Pizzo P, Yaffe D, Nudel U. Reduced levels of dystrophin associated proteins in the brains of mice deficient for Dp71. Hum Mol Gen. 5:1996;1299-1303.
46. Blank M, Koulen P, Kröger S. Subcellular concentration of β-dystroglycan in photoreceptors and glial cells of the chick retina. J Comp Neur. 389:1997;668-678.
47. Koulen P, Blank M, Kröger S. Differential distribution of beta-dystroglycan in rabbit and rat retina. J Neurosci Res. 51:1998;735-747.
48. Kameya S, Araki E, Katsuki M, Mizota A, Adachi E, Nakahara K, Nonaka I, Sakuragi S, Takeda S, Nabeshima Y. Dp260 disrupted mice revealed prolonged implicit time of the b-wave in ERG and loss of accumulation of β-dystroglycan in the outer plexiform layer of the retina. Hum Mol Gen. 6:1997;2195-2203.
49. Belkin AM, Smalheiser NR. Localization of cranin (dystroglycan) at sites of cell-matrix and cell-cell contact: recruitment to focal adhesions is dependent upon extracellular ligands. Cell Adhes Comm. 4:1996;281-296.
50. Ettinger AJ, Feng G, Sanes JR. ε-sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J Biol Chem. 272:1997;32534-32538.
51. Durbeej M, Jung D, Hjalt T, Campbell KP, Ekblom P. Transient expression of Dp140, a product of the Duchenne muscular dystrophy locus, during kidney tubulogenesis. Dev Biol. 181:1997;156-167.
52. Apel EA, Glass DJ, Moscoso LM, Yancopoulos GD, Sanes JR. Rapsyn is required for MuSK signaling and recruits synaptic components to a MuSK-containing scaffold. of special interest Neuron. 18:1997;623-635 An elegant demonstration showing that rapsyn is linked to MuSK via a trans-membrane intermediate, has a signalling role in agrin induced differentiation and is associated with acetylcholine receptors.
53. Cartaud A, Coutant S, Petrucci TC, Cartaud J. Evidence for in situ and in vitro association between β-dystroglycan and the subsynaptic 43 K rapsyn protein. J Biol Chem. 273:1998;11321-11326.
54. Sugiyama JE, Glass DJ, Yancopoulos GD, Hall ZW. Laminin-induced acetylcholine receptor clustering: an alternative pathway. of special interest J Cell Biol. 139:1997;181-191 These authors show that laminin 1 specifically induces acetylcholine receptor clustering in C2-myotubes by a pathway independent of that used by agrin. Moreover, it is shown that laminin 1 induced clustering does not require the muscle specific receptor tyrosine kinase MuSK.
55. Cohen MW, Jacobson C, Yurchenco PD, Morris GE, Carbonetto S. Laminin-induced clustering of dystroglycan on embryonic muscle cells: comparison with agrin induced clustering. of special interest J Cell Biol. 136:1997;1047-1058 Data presented here suggest that mobile dystroglycan on the surface of embryonic muscle cells can be trapped by at least two sets of molecular interactions.
56. Sorokin LM, Conzelmann S, Ekblom P, Battaglia C, Aumailley M, Timpl R. Monoclonal antibodies against laminin A chain fragment E3 and their effects on binding to cells and proteoglycan and on kidney development. Exp Cell Res. 210:1992;137-144.
57. Kadoya Y, Kadoya K, Durbeej M, Holmvall K, Sorokin L, Ekblom P. Antibodies against domain E3 of laminin-1 and integrin α6 subunit perturb branching morphogenesis of submandibular gland, but by different modes. J Cell Biol. 129:1995;521-534.
58. Gesemann M, Brancaccio A, Schumacher B, Ruegg MA. Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. of special interest J Biol Chem. 273:1998;600-605 The data presented show that an isoform of agrin, that does not induce post-synaptic specializations, is highly expressed in several non-muscle tissues. Moreover, this agrin isoform binds with high affinity to α-dystroglycan.
59. Yang B, Jung D, Motto D, Meyer J, Koretzky G, Campbell KP. SH3 domain mediated interaction of dystroglycan and Grb2. J Biol Chem. 270:1995;11711-11714.
60. Roberds SL, Ervasti JM, Anderson RD, Ohlendieck K, Kahl SD, Zoloto D, Campbell KP. Distribution of the dystrophin-glycoprotein complex in the cardiomyopathic hamster. J Biol Chem. 268:1993;11496-11499.
61. Straub V, Duclos F, Venzke D, Lee JC, Cutshall S, Leveille CJ, Campbell KP. Molecular pathogenesis of muscle degeneration in the δ-sarcoglycan deficient hamster. Am J Pathol. 1998;. in press.
62. Okazaki Y, Okuizumi H, Ohsumi T, Nomura O, Takada S, Kamiya M, Sasaki N, Matsuda Y, Nishimura M, Tagaya O, et al. A genetic linkage map of the syrian hamster and localization of cardiomyopathy locus on chromosome 9qa2.1-b1 using RLGS spot-mapping. Nat Genet. 13:1996;87-90.
63. Nigro V, Okazaki Y, Belsito A, Piluso G, Matsuda Y, Politano L, Nigro G, Ventura C, Abbondanza C, Molinaro AM, et al. Identification of the syrian hamster cardiomyopathy gene. Hum Mol Gen. 6:1997;601-617.
64. Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, Masaki T, Toyo-Oka T, Hanaoka F. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA. 94:1997;13873-13878.
65. Holt KH, Lim LE, Straub V, Venzke DP, Duclos F, Anderson RD, Davidson BL, Campbell KP. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using δ-sarcoglycan gene transfer. of outstanding interest Mol Cell. 1:1998;841-848 A convincing demonstration of the power of sarcoglycan gene transfer for limb-girdle muscular dystrophy using recombinant δ-sarcoglycan adenovirus in the BIO 14.6 hamster is presented. Among other things, the authors demonstrate a long term-expression of δ-sarcoglycan, rescue of the entire sarcoglycan complex, a restored association of α-dystroglycan with the sarcolemma and restored plasma membrane integrity.
66. Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, Holt KH, et al. Progressive muscular dystrophy in α-sarcoglycan deficient mice. of special interest J Cell Biol. 1998; α-sarcoglycan deficient mice exhibit loss of the entire sarcoglycan complex, sarcospan and a disruption of α-dystroglycan association with membranes.
67. Duclos F, Broux O, Bourg N, Straub V, Feldman GL, Sunada Y, Lim LE, Piccolo F, Cutsall S, Gary F, et al. Beta-sarcoglycan: genomic analysis and identification of a novel missense mutation in the LGMD2E amish isolate. Neuromuscul Disord. 8:1998;30-38.
68. Kobayashi K, Nakahori Y, Miyake M, Matsumura K, Kondo-Lida E, Nomura Y, Segawa M, Yoshioka M, Saito K, Osawa M, et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature. 394:1998;388-392.
69. Matsumura K, Nonaka I, Campbell KP. Abnormal expression of dystrophin-associated proteins in Fukuyama-type congenital muscular dystrophy. Lancet. 341:1993;521-522.
70. Hayashi YK, Engvall E, Arikawa-Hirasawa E, Goto K, Koga R, Nonaka I, Sugita H, Arahata K. Abnormal localization of laminin subunits in muscular dystrophies. J Neurol. 119:1993;53-64.
71. Rambukkana A, Salzer JL, Yurchenco PD, Tuomanen EI. Neural targeting of mycobacterium leprae mediated by the G-domain of the laminin-alpha 2 chain. of special interest Cell. 88:1997;811-821 The authors mapped the Mycobacterium leprae binding site to the G-domain of the laminin α2 chain. This binding was shown to be partially blocked by an antibody against the β4 integrin subunit, suggesting that also integrins may be involved in M. leprae invasion.